BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 10716964)

  • 21. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology.
    Dickson EL; Vogel RI; Bliss RL; Downs LS
    Int J Gynecol Cancer; 2013 Sep; 23(7):1295-302. PubMed ID: 23970156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related changes of the cervix influence human papillomavirus type distribution.
    Castle PE; Jeronimo J; Schiffman M; Herrero R; Rodríguez AC; Bratti MC; Hildesheim A; Wacholder S; Long LR; Neve L; Pfeiffer R; Burk RD
    Cancer Res; 2006 Jan; 66(2):1218-24. PubMed ID: 16424061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus types distribution in organised cervical cancer screening in France.
    Heard I; Tondeur L; Arowas L; Falguières M; Demazoin MC; Favre M
    PLoS One; 2013; 8(11):e79372. PubMed ID: 24244490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.
    Safaeian M; Herrero R; Hildesheim A; Quint W; Freer E; Van Doorn LJ; Porras C; Silva S; González P; Bratti MC; Rodriguez AC; Castle P;
    J Clin Microbiol; 2007 May; 45(5):1447-54. PubMed ID: 17344361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of human papillomavirus infection among women from quilombo communities in northeastern Brazil.
    Nascimento MDDSB; Vidal FCB; Silva MACND; Batista JE; Lacerda Barbosa MDC; Muniz Filho WE; Bezerra GFB; Castro Viana GM; Branco RCC; Brito LMO
    BMC Womens Health; 2018 Jan; 18(1):1. PubMed ID: 29291721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2.
    Zhao Y; Cao X; Zheng Y; Tang J; Cai W; Wang H; Gao Y; Wang Y
    J Med Virol; 2012 Dec; 84(12):1920-7. PubMed ID: 23080497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study.
    Franceschi S; Rajkumar T; Vaccarella S; Gajalakshmi V; Sharmila A; Snijders PJ; Muñoz N; Meijer CJ; Herrero R
    Int J Cancer; 2003 Oct; 107(1):127-33. PubMed ID: 12925967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of women infected with human papillomavirus in a tertiary hospital in Beijing China, 2014-2018.
    Ma L; Lei J; Ma L; Cong X; Wang N; Yang H; Liu Q; Yu Y; Cao Y
    BMC Infect Dis; 2019 Jul; 19(1):670. PubMed ID: 31357941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia.
    Chang DY; Chen RJ; Lee SC; Huang SC
    J Med Microbiol; 1997 Jan; 46(1):54-60. PubMed ID: 9003746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
    Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
    CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women.
    Hwang T
    J Korean Med Sci; 1999 Dec; 14(6):593-9. PubMed ID: 10642935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
    Garland SM; Joura EA; Ault KA; Bosch FX; Brown DR; Castellsagué X; Ferenczy A; Ferris DG; Giuliano AR; Hernandez-Avila M; Huh WK; Iversen OE; Kjaer SK; Kurman RJ; Luna J; Monsonego J; Muñoz N; Paavonen J; Pitisuttihum P; Ronnett BM; Steben M; Stoler MH; Wheeler CM; Wiley DJ; Perez G; Saah AJ; Luxembourg A; Li S; DiNubile MJ; Wagner M; Velicer C
    Obstet Gynecol; 2018 Aug; 132(2):261-270. PubMed ID: 29995724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,
    Bratti MC; Rodríguez AC; Schiffman M; Hildesheim A; Morales J; Alfaro M; Guillén D; Hutchinson M; Sherman ME; Eklund C; Schussler J; Buckland J; Morera LA; Cárdenas F; Barrantes M; Pérez E; Cox TJ; Burk RD; Herrero R
    Rev Panam Salud Publica; 2004 Feb; 15(2):75-89. PubMed ID: 15030652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of human papillomavirus genotypes in Paraguayan women according to the severity of the cervical lesion.
    Mendoza LP; Arbiza J; Paez M; Kasamatsu E; Castro A; Giménez G; Basiletti J; Gonzalez J; Mongelós P; Picconi MA
    J Med Virol; 2011 Aug; 83(8):1351-7. PubMed ID: 21618554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.